MedPath

Study on itraconazole vs griseofulvin in treatment of tinea.

Phase 4
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2024/01/061906
Lead Sponsor
Eras Lucknow Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Freshly diagnosed patients of age 18 years and above with clinical diagnosis of tinea corporis and tinea cruris confirmed by potassium hydroxide (KOH) test attending the dermatology OPD at ELMC&H.

Exclusion Criteria

Previously treated patient within 3 months.Patients with pre-existing renal disease, hepatic disease and cardiac disease.Pregnant & lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath